Novel NS5B Resistance‐Associated Substitution Emerges Under Failing Sofosbuvir/Ledipasvir Therapy

Clinical Liver Disease - United Kingdom
doi 10.1002/cld.768
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy

Hepatology Communications
Hepatology
2019English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2016English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

Hepatology
MedicineHepatology
2018English

Ledipasvir and Sofosbuvir for HCV-infection in Patients Coinfected With HBV

Antiviral Therapy
Infectious DiseasesPharmacology
2016English

Sofosbuvir Plus Ledipasvir for Recurrent Hepatitis C in Liver Transplant Recipients

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Sofosbuvir/Ledipasvir and Ribavirin Tolerability and Efficacy in Pediatric Liver Transplant Recipients

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants During SOF/LDV Combination Therapy Against Genotype 1b Hepatitis C Virus (HCV)

Scientific Reports
Multidisciplinary
2017English

Investigation of Pharmacokinetic Interactions Between Doravirine and Elbasvir/Grazoprevir and Ledipasvir/Sofosbuvir

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy